Taking the drug may also increase the risk of chronic kidney disease by 19 per cent, heart failure by 9 per cent and ...

A new study indicates that paracetamol, an over-the-counter medication, may heighten risks for gastrointestinal, heart, and kidney issues among adults aged 65 and above. The medication's effectiveness ...

"I would tell them I'm forever beholden to them," Pat Svacina said. "Tell them I'm so thankful for their generosity. It's ...

A new treatment option for patients with uncontrollable high blood pressure is now available at Willis Knighton Health.

Flowel and Flowel Plus are not indicated for the treatment of prostate cancer ... If prostate enlargement is left untreated, ...

"The insurance company denied the simple procedure to correct the condition, saying it was 'pre-existing' because the baby was born that way." View Entire Post › ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...